Citation: Ka. Laessig et al., The role of resistance testing in clinical trial design and product labelling: a regulatory perspective, ANTIVIR TH, 5(1), 2000, pp. 77-83
Authors:
Rosen, H
Muhlestein, JB
Bartlett, J
Chen, S
Chikami, G
Corson, M
Shah, PK
Gurfinkel, E
Handsfield, H
Jackson, L
Knirsch, C
Kronmal, R
McCutchan, JA
Shea, S
Citation: H. Rosen et al., Collaborative multidisciplinary workshop report: Clinical antimicrobial trials for primary and secondary prevention of atherosclerotic cardiovasculardisease, J INFEC DIS, 181, 2000, pp. S582-S584